Literature DB >> 25345933

[miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3].

Xuejun Guo1, Chuanhui Cao, Jingyuan Sun, Dongyan Zhang, Li Liu, Dehua Wu.   

Abstract

OBJECTIVE: To investigate the expression of microRNA-128a (miR-128a) and its role in hepatocellular carcinoma (HCC).
METHODS: Nineteen pairs of fresh surgical specimens of HCC and adjacent tissues were examined for miR-128a expression using qRT-PCR. A miR-128a mimics or inhibitor was transfected into HCC cells, and the cell viability was analyzed by MTT assay. RND3, one of the potential targets of miR-128a, was predicted by bioinformatics software and demonstrated by dual luciferase reporter assay. The expression of RND3 after transfection was detected using qRT-PCR and Western blotting, and the cell cycle-related proteins were determined with Western blotting.
RESULTS: The expression of miR-128a were significantly up-regulated in HCC tissues as compared to the adjacent tissues (P<0.05). In cultured HCC cells, miR-128a promoted the cell proliferation and resulted in down-regulated RND3 mRNA and protein expressions by targeting RND3' 3'UTR (P<0.05) and also in the down-regulation of cyclin B1, cyclin D1 and CDK4 protein expressions.
CONCLUSION: miR-128a is up-regulated in HCC and promotes HCC cell proliferation by targeting RND3.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25345933

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  1 in total

1.  A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies.

Authors:  Feifei Wang; Ruliang Wang; Qiuwen Li; Xueling Qu; Yixin Hao; Jingwen Yang; Huixia Zhao; Qian Wang; Guanghui Li; Fengyun Zhang; He Zhang; Xuan Zhou; Xioumei Peng; Yang Bian; Wenhua Xiao
Journal:  Diagn Pathol       Date:  2017-01-13       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.